How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy by Paolo Spallarossa, Matteo Sarocchi, Giacomo Tini, Giacomo Tini, Eleonora Arboscello, Matteo Toma, Matteo Toma, Pietro Ameri, Pietro Ameri, Italo Porto, Italo Porto

Subjects: “…checkpoint inhibition therapy…”
Get full text

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies by Zena N. Willsmore, Robert J. Harris, Silvia Crescioli, Khuluud Hussein, Helen Kakkassery, Deepika Thapa, Anthony Cheung, Anthony Cheung, Jitesh Chauhan, Heather J. Bax, Heather J. Bax, Alicia Chenoweth, Alicia Chenoweth, Roman Laddach, Roman Laddach, Gabriel Osborn, Alexa McCraw, Ricarda M. Hoffmann, Mano Nakamura, Jenny L. Geh, Alastair MacKenzie-Ross, Ciaran Healy, Sophia Tsoka, James F. Spicer, Sophie Papa, Sophie Papa, Linda Barber, Katie E. Lacy, Sophia N. Karagiannis, Sophia N. Karagiannis

Subjects: Get full text

Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases by Juan Aguilar-Company, Juan Aguilar-Company, Maria A. Lopez-Olivo, Isabel Ruiz-Camps, Isabel Ruiz-Camps, Isabel Ruiz-Camps

Subjects: “…checkpoint inhibition therapy…”
Get full text

The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure? by Hui Chen, Hui Chen, Maha Moussa, Marta Catalfamo

Subjects: Get full text

Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells by Sugandha Narayan, Rajdeep Dalal, Zaigham Abbas Rizvi, Zaigham Abbas Rizvi, Amit Awasthi, Amit Awasthi

Subjects: “…checkpoint inhibition therapy…”
Get full text

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? by Alec S. Britt, Caitlyn Huang, Chao H. Huang, Chao H. Huang

Subjects: “…checkpoint inhibition therapy…”
Get full text

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition by Irantzu Anzar, Irantzu Anzar, Brandon Malone, Pubudu Samarakoon, Ioannis Vardaxis, Boris Simovski, Hugues Fontenelle, Leonardo A. Meza-Zepeda, Leonardo A. Meza-Zepeda, Richard Stratford, Emily Z. Keung, Melissa Burgess, Hussein A. Tawbi, Ola Myklebost, Ola Myklebost, Trevor Clancy

Subjects: Get full text

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia by Kyle A. Romine, Daniel Bottomly, Daniel Bottomly, William Yashar, William Yashar, Nicola Long, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney, Shannon K. McWeeney, Jeffrey W. Tyner, Jeffrey W. Tyner

Subjects: Get full text

Co-Inhibitory Molecules – Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events by Stinne R. Greisen, Stinne R. Greisen, Maithri Aspari, Bent Deleuran, Bent Deleuran

Subjects: Get full text

Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies by Paraskevi Vryza, Timo Fischer, Elena Mistakidi, Apostolos Zaravinos

Subjects: Get full text

Editorial: Genetic and Epigenetic Control of Immune Responses by Satish kumar R. Noonepalle, Lidia Karabon, Katherine B. Chiappinelli, Alejandro Villagra

Subjects: Get full text

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden by George Georgoulias, Apostolos Zaravinos, Apostolos Zaravinos

Subjects: Get full text

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma by Francinne T. Tostes, Miguel Zugman, Vitor R. Paes, Gustavo Schvartsman

Subjects: Get full text